Related Experiment Video
Updated: Jul 28, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clustering of clinical and echocardiographic phenotypes of covid-19 patients
Eran Shpigelman1, Aviram Hochstadt2,3,4, Dan Coster1
1The Blavatnik School of Computer Science, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel.
Insights
COVID-19 patients were classified into four subgroups using clinical and echocardiography data. These COVID-19 patient clusters revealed distinct disease patterns and prognoses, aiding in understanding heterogeneous cardiac involvement.
Area of Science:
- Cardiology
- Infectious Diseases
- Data Science
Background:
- COVID-19 infection causes heterogeneous cardiac involvement.
- Understanding distinct patient phenotypes is crucial for elucidating disease pathogenesis.
Purpose of the Study:
- To stratify hospitalized COVID-19 patients into distinct phenotypical subgroups.
- To investigate the role of echocardiography and clinical markers in predicting COVID-19 patient outcomes.
Main Methods:
- Applied k-prototypes algorithm to clinical and echocardiography data of 506 hospitalized COVID-19 patients.
- Utilized Cox proportional hazard model to assess survival patterns across identified clusters.
- Analyzed echocardiography variables for their discriminative power.
Main Results:
- Four distinct patient clusters were identified based on age, cardiac indexes, and inflammatory response.
- Clusters exhibited significantly different survival patterns, with Cluster 3 showing the worst prognosis.
- Echocardiography-derived clusters demonstrated higher mortality prediction than clinical data alone.
- Specific echocardiography variables (E' lat, E' sept, E/e average) showed high discriminative power.
Conclusions:
- COVID-19 presents with distinct manifestations and prognoses across different patient clusters.
- Echocardiography enhances the predictive power for mortality but its incremental value may not justify the data collection burden.
- Older males with COVID-19 face a higher risk of deterioration compared to older females.
Abstract:
We sought to divide COVID-19 patients into distinct phenotypical subgroups using echocardiography and clinical markers to elucidate the pathogenesis of the disease and its heterogeneous cardiac involvement. A total of 506 consecutive patients hospitalized with COVID-19 infection underwent complete evaluation, including echocardiography, at admission. A k-prototypes algorithm applied to patients' clinical and imaging data at admission partitioned the patients into four phenotypical clusters: Clusters 0 and 1 were younger and healthier, 2 and 3 were older with worse cardiac indexes, and clusters 1 and 3 had a stronger inflammatory response. The clusters manifested very distinct survival patterns (C-index for the Cox proportional hazard model 0.77), with survival best for cluster 0, intermediate for 1-2 and worst for 3. Interestingly, cluster 1 showed a harsher disease course than cluster 2 but with similar survival. Clusters obtained with echocardiography were more predictive of mortality than clusters obtained without echocardiography. Additionally, several echocardiography variables (E' lat, E' sept, E/e average) showed high discriminative power among the clusters. The results suggested that older infected males have a higher chance to deteriorate than older infected females. In conclusion, COVID-19 manifests differently for distinctive clusters of patients. These clusters reflect different disease manifestations and prognoses. Although including echocardiography improved the predictive power, its marginal contribution over clustering using clinical parameters only does not justify the burden of echocardiography data collection.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification

